We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

MobileMedMinder: A Networked Aide for Medication Compliances

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01597583
First Posted: May 14, 2012
Last Update Posted: December 10, 2013
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
Limaging
Information provided by (Responsible Party):
Steve Gottlieb, University of Maryland
May 10, 2012
May 14, 2012
December 10, 2013
November 2011
December 2013   (Final data collection date for primary outcome measure)
Compliance [ Time Frame: 3 months ]
Pill counts will be used to assess compliance
Same as current
Complete list of historical versions of study NCT01597583 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
MobileMedMinder: A Networked Aide for Medication Compliances
MobileMedMinder: A Networked Aide for Medication Compliances
The main aim of this study is to conduct a randomized control trial to compare MobileMedMinder, a mobile phone based medication reminder software product, with currently accepted and empirically supported methods for increasing medication compliance through reminders and tracking.
Not Provided
Interventional
Not Provided
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Heart Failure, Congestive
Behavioral: Use of MobileMedMinder
Use of an intervention to remind patients to take their medications.
  • Experimental: Use of MobileMedMinder
    Intervention: Behavioral: Use of MobileMedMinder
  • No Intervention: Usual care
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
50
December 2013
December 2013   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Taking beta blockers, ACE or ARB, and hydralazine for treatment of HF.

Exclusion Criteria:

  • Inability to understand informed consent
  • Inability to read and understand English
Sexes Eligible for Study: All
18 Years and older   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
United States
 
 
NCT01597583
HP-00051021
Yes
Not Provided
Not Provided
Steve Gottlieb, University of Maryland
University of Maryland
Limaging
Not Provided
University of Maryland
December 2013

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP